For twenty-five years, the phrase “genital herpes” has been like a sentence of death to most of my patients. When you were infected, you were infected for life — that had been the rule. But in 2025, that narrative is starting to change.
With recent developments that seem to hold cures to multiple strains of the herpes virus, the world looks as though it’s headed for a dramatic change in the fight against herpes simplex virus type 2 (HSV-2) — a sexually transmitted illness that affects an estimated 14 per cent of the global population aged 15 to 49 years.
So then the obvious question: Is there a cure for genital herpes in 2025?
So let’s dive deep into what science, medicine, and continuing clinical trials reveal.
What is Genital Herpes?
Genital herpes is a prevalent STI caused by HSV-2 (and, to some extent, HSV-1). It leads to painful sores, itching, and burning in the genital area. More ominously, though, the virus can lie dormant inside the body’s nerve cells and reactivate later, sometimes with symptoms, sometimes without.
This “hiding” is what makes herpes so hard to cure. Medications such as acyclovir, valacyclovir and famciclovir can control outbreaks but not the virus itself. That is why it has been so challenging to find a cure.
Why 2025 Feels Different
For decades, the approach to treating herpes has been to manage symptoms, reduce the frequency of outbreaks, and minimise the risk of spreading the virus.
But 2025 has ushered in a Tide of innovation aimed at killing off the virus, or at least reducing it to the point of no resurgence or transmission.
Here’s what’s changed:
IM-250: The New Antiviral Everyone is Talking About
In June 2025, Innovative Molecules GmbH announced that patient enrollment was finished for a Phase 1b/2a clinical trial of IM-250, a novel once-weekly oral drug, unlike past antivirals, such as Im-250, which were developed to enter the nerve tissue and stop replication of herpes more efficiently.
Its mechanism of action homes in on the virus’s helicase-primase complex, which is a key element of how HSV replicates itself. That means it could be a potential tool in getting to the latent virus reservoirs, which are the holy grail of herpes treatment.
While IM-250 is not a cure (yet), it could be the best long-term suppression therapy known to date, potentially approaching a functional cure.
ABI-5366: Monthly Treatment, Daily Impact
Another leading candidate is ABI-5366, made by Assembly Biosciences. It is in early clinical trials as of mid-2025, and is being studied for the potential to be taken once a month, providing relief and suppression with far fewer pills and fewer side effects.
Early data shared at the ESCMID Global Congress 2025 indicated ABI-5366 could be effective in reducing viral shedding and reactivation, and potentially transmission during the asymptomatic stage.
Gene Editing: Taking the Fight to the Source
Among the most revolutionary work is being done at the Fred Hutchinson Cancer Research Centre in Seattle, where researchers, including Dr. Keith Jerome, are studying gene-editing enzymes as a treatment, while others are exploring a vaccine.“The prime editing has the potential to erase the virus from the body,” Dr. Jerome said.
In 2024, they reported preclinical findings in which they used meganucleases — synthesised enzymes that cut herpes DNA while sparing human DNA — to achieve a more than 90% reduction in HSV-1 in infected mice.
While this research was on oral herpes, the genetic structure of HSV-1 and HSV-2 isn’t that different. And these results bode well for future human studies looking to treat — and maybe even cure — genital herpes, too.
The preclinical data do, however, look hopeful that, in a few years, we may finally have our first curative approach, even if no human trials have been made public as of mid-2025.
Therapeutic Vaccines and mRNA Technology
Immunisations are not just for prevention anymore. By 2025, researchers will be using therapeutic vaccines to retrain the body’s immune system to aggressively suppress — or perhaps eliminate — HSV.
Among the most promising is that of Dr. David Koelle at the University of Washington. His team is developing a herpes vaccine that helps T-cell immunity using mRNA-based technology, which also underlies the COVID-19 vaccines.
In June 2025, his lab was awarded a $275,000 grant to help further work on this HSV-2 vaccine that could potentially curb and/or eradicate symptoms and viral shedding.
Other companies are developing herpes vaccines, too, and at least two potential ones have shown positive results in placebo-controlled trials carried out thus far by those companies: Rational Vaccines and an unnamed company working with BioNTech Group, based in Mainz, Germany, as well as Sanofi.
So, Is There a Cure?
First, we need to make clear what we’re talking about when referring to a “cure”:
A suppressive treatment will minimise but not eradicate symptoms and outbreaks, as the virus never leaves the body.
A functional cure means that the virus no longer reactivates and is not transmissible even if, strictly speaking, it still exists in the body.
Curing means eradicating the virus from the body.
As of 2025:
No cure is approved for genital herpes.
Recently, several novel treatments, such as IM-250 and ABI-5366, have provided strong inhibition with fewer side effects.
Gene-editing therapy has the potential to offer a functional or even total cure on the near horizon, but it’s still in the pre-human trial stage.
Treatment vaccines could be game changers for immune control and outbreak suppression in the long run.
In brief: We do not yet have a cure, but we are getting closer.
What You Can Do Now
If you’re crying to live with genital herpes in 2025, here’s what you can do:
Talk with a provider: See if you are eligible for clinical trials, or new drugs may be available in your region.
Stay informed: Stick with reliable sources such as ClinicalTrials. Gov, Fred Hutch and Assembly Biosciences for the most current.
Join support communities: Online groups, such as Reddit’s r/HerpesCureResearch, and patient-led nonprofits can help you stay informed and gain support.
Caring for yourself: Stress, sleep and immune health management can lead to less frequent and less severe outbreaks.
A Look Ahead
The herpes cure effort has evolved during the past five years, and 2025 is our milestone year. This is not just about managing outbreaks but about creating real science-backed avenues for ending them forever.
The search is ongoing, from gene-editing labs to antiviral drugmakers. And each trial brings us one step closer to changing the lives of the millions of people who live with genital herpes.
It’s not here today, but the genital herpes cure of tomorrow is finally in sight.
Disclaimer: This story is for informational purposes only and is not a substitute for medical advice. Treatment options may not always be up to date, specialised, or available.
